ROCKET PHARMACEUTICALS INC (RCKT) Institutional Ownership

RCKT is currently held by 2 institutional investors tracked by InsiderSet, with a combined reported market value of approximately $2.35M based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026.

The largest disclosed holder is Renaissance Technologies LLC, which reported ownership valued at approximately $2.28M in its March 31, 2026 13F filing. Based on current market prices and the latest disclosed share count, Renaissance Technologies LLC's RCKT position is now estimated to be worth approximately $2.18M, representing an estimated loss of -4.47% since the filing period.

Major shareholders tracked on this page include Renaissance Technologies LLC, Sequoia Financial Advisors, and other prominent asset managers. Collectively, these investors account for approximately 100% of the total disclosed value among the investors covered in this analysis.

This page tracks 13F-reported ownership trends, hedge fund exposure, portfolio concentration, historical 13F filings, and estimated holding performance to help investors analyze smart money sentiment toward ROCKET PHARMACEUTICALS INC (RCKT).

Institutional Ownership Trend

Portfolio quarterInstitutional holdersTotal reported valueTotal shares
Q1 20262$2,353,933657,523
Q4 20252$1,520,621433,225
Q3 20251$447,197137,177
Q2 20251$1,130,366461,374
Q1 20252$3,040,020455,775
Q4 20242$4,281,518340,614
Q3 20241$1,356,14173,424
Q2 20242$3,590,988166,790
Q1 20241$1,641,5358,689
Q4 20232$1,825,732123,530
Q3 20232$1,236,991253,651
Q2 20232$1,084,86083,443